Mutated Protein L Polypeptides for Alkali-Stable Chromatography

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current Protein L matrices used in affinity chromatography are alkali-sensitive, limiting their stability during cleaning processes, which necessitates the use of additional cleaning agents and reduces their effectiveness in maintaining binding capacity over multiple cycles.

Innovation Solution

Development of polypeptides with improved alkaline stability by mutating specific amino acids in the kappa light chain-binding domains of Peptostreptococcus magnus Protein L, such as N45A, N10Q, and N60Q mutations, forming multimers that retain high selectivity for kappa light chain-containing proteins and withstand alkaline conditions during cleaning.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If Protein L matrices are used in affinity chromatography, then high selectivity for kappa light chain-containing proteins is achieved, but alkaline stability deteriorates (only tolerates up to about 15 mM NaOH)

Engineering Contradiction:
ImproveselectivityVSAvoidalkaline stability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent applies parameter changes by mutating specific amino acid residues in the Protein L sequence (positions 10, 45, and 60) to alter the chemical properties of the polypeptide. These mutations (e.g., N10Q, N45A, N60Q) change the local structure and chemical environment to resist alkaline degradation while preserving the overall binding function to kappa light chains.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates composite structures by combining multiple stabilized domains (Domain 3 with mutations, and optionally other domains) into multimeric polypeptides. This composite approach distributes the structural stress and binding function across multiple stabilized units, enhancing overall alkaline stability while maintaining selectivity.

Inventive Principle:
Principle #40Composite materials

2Ease of operation

If additional cleaning agents (urea or guanidinium salts) are used to ensure sufficient cleaning, then cleaning effectiveness is improved, but process complexity and cost increase

Engineering Contradiction:
Improvecleaning effectivenessVSAvoidcleaning process complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent extracts and removes the vulnerable asparagine residues at critical positions (10, 45, 60) from the Protein L sequence and replaces them with more alkaline-resistant amino acids. This extraction of problematic residues eliminates the need for complex multi-agent cleaning protocols, allowing simple NaOH cleaning to suffice.

Inventive Principle:
Principle #2Taking out (Extraction)

3Productivity

If Protein L matrices are subjected to repeated cleaning cycles, then matrix regeneration is achieved, but binding capacity deteriorates due to alkaline sensitivity

Engineering Contradiction:
Improvematrix reusabilityVSAvoidbinding capacity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent performs preliminary stabilization by pre-mutating the amino acid residues to alkaline-resistant variants before the matrix is subjected to cleaning cycles. This preliminary structural modification prevents damage during subsequent cleaning operations, preserving binding capacity throughout the matrix lifecycle and enabling repeated use.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The mutated polypeptides exhibit enhanced alkaline stability, maintaining at least 40% of their binding capacity after 96 cycles in 0.1 M NaOH, significantly improving the durability and efficiency of the separation matrix for repeated use in bioprocesses.

Implementation Method 1

The present invention relates to the field of affinity chromatography, and more specifically to polypeptides comprising kappa light chain-binding domains of Protein L, which are useful in affinity chromatography of many types of immunoglobulins and immunoglobulin fragments

Methodology Applied
Scientific EffectAffinity chromatography: Adsorption

Data Source

PatentEP3233891B1Modified kappa light chain-binding polypeptides
Publication Date: 2024.03.13 CYTIVA BIOPROCESS R&D AB
  • EP3233891B1 patent drawingFigure 1
  • EP3233891B1 patent drawingFigure 2
  • EP3233891B1 patent drawingFigure 3

AI summary

A kappa light chain-binding polypeptide comprising or consisting essentially of one or more binding domains of Peptostreptococcus Protein L, each of said domains being selected from the group consisting of domain 2, domain 3 and domain 4.